Dr Sumana Chandramouli | Laboratory Head, Preclinical R&D
GSK Vaccines | United States

Dr Sumana Chandramouli, Laboratory Head, Preclinical R&D, GSK Vaccines

Appearances:



DC Pre-congress WS day April 2 @ 09:00

Advances in using structure-based knowledge for smarter vaccine designs

Structure-based vaccines are designed on the rationale that protective epitopes should be sufficient to induce immune responses and provide protection against pathogens, with multiple epitopes inducing a higher immune response. Structure-based vaccines have become a much-anticipated field over the years with increasingly more preclinical and clinical staged developments. This workshop focuses on recent advances and their application in providing protection against infectious diseases.

Progress in Stabilized Pre-fusion Glycoprotein Vaccines for Paramyxoviruses & HIV-1

Using structural based vaccine design to target flavivirus infections: Zika and Dengue

GSK’s CMV structural biology research

Discussion with all speakers
 

back to speakers